Valuation (93%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 10.05 | N/A |
| PEG Ratio (TTM) | 0.32 | N/A |
| P/S Ratio (TTM) | 0.89 | N/A |
| P/B Ratio (TTM) | 0.85 | N/A |
| P/FCF Ratio (TTM) | 4.23 | N/A |
| Price to 5YR AVG Earnings Ratio | 9.10 | N/A |
| Price to 5YR AVG FCF Ratio | 13.08 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.97% | N/A |
| ROE (TTM) | 9.02% | N/A |
| Net Profit Margin (TTM) | 8.92% | N/A |
| ROIC 5YR AVG | 5.74% | N/A |
Growth (77%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 45.50% | 107.46% | 49.00% |
| Revenue | 2.65% | 23.03% | 6.72% |
| Net Income | 48.01% | 110.56% | 50.62% |
| Cash Flow | 44.97% | -346.16% | -221.40% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.01 | N/A |
| Quick Ratio (TTM) | 0.01 | N/A |
| D/E Ratio (TTM) | 0.31 | N/A |
| Interest Coverage (TTM) | 7.28 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | 4.27 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.25% | N/A |